Dr. Greg Raskin (JE 94, MED 98) is the Vice President of Technology Development at Memorial Sloan Kettering Cancer Center in New York City. In this role, he leads efforts to ensure that promising discoveries made in MSK’s laboratories are further developed and commercialized. Prior to re-entering the world of academic medicine in 2012, Greg worked for a decade as an investor in public and private biotechnology companies; for a few years as a management consultant to pharmaceutical companies; and briefly as a medical resident. Greg is a Lecturer in Yale College, co-teaching an undergraduate seminar on biotechnology and drug development. He’d be happy to talk to students about careers at the intersection of business and medicine.
